Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study

By sjmartinez • February 4, 2025

Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan SY, Phillip Koeffler H, Ding L, Chen YQ, Feng N. Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study. Br J Cancer. 2025 Feb 3. doi: 10.1038/s41416-025-02947-0. Epub ahead of print. PMID: 39900986.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Accelerating CEST MRI With Deep Learning-Based Frequency Selection and Parameter Estimation

Shen C, Cheema K, Xie Y, Ruan D, Li D. Accelerating CEST MRI With Deep Learning-Based Frequency Selection and Parameter Estimation. NMR Biomed. 2025 Jul;38(7):e70068.[...]

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial

Lau G, Sangro B, Cheng AL, Kudo M, Kelley RK, Tak WY, Gasbarrini A, Reig M, Lim HY, Tougeron D, De Toni EN, Tam VC,[...]

How I do it: Best practices for right heart catheterization in the diagnosis of pulmonary hypertension

Matusov Y, Kolaitis NA, Geft D, DesJardin J, Barnett C, Hage A, De Marco T, Lewis MI. How I do it: Best practices for right[...]